Skip to content
Screener

Quest Diagnostics DGX Prepaid & Other Current

Prepaid & Other Current at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$34.7M+7.1%
Labcorp Holdings logo
Labcorp HoldingsLH
$23.1M-96.5%
Opko Health logo
Opko HealthOPK
$55.74M-5.3%
NeoGenomics logo
NeoGenomicsNEO
$234K+17.6%
Exagen Inc. logo
Exagen Inc.XGN
$6.3M-4.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$5.03M+3.9%

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$26.03B+34.6%
Enterprise value$31.79B+25.1%
P/E24.5×+4.1×
P/S2.3×+0.4×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001022079-26-000070
Line itemJune 30,2026December 31,2025
Cash and cash equivalents$626$420
Accounts receivable, net of allowance for credit losses of $28 and $25 as of June 30, 2026 and December 31, 2025, respectively1,6661,408
Inventories233189
Prepaid expenses and other current assets319361
Total current assets2,8442,378
Property, plant and equipment, net2,2192,203
Operating lease right-of-use assets678657
Goodwill9,1128,945

Cover / Front Matter

FAQ

What is Quest Diagnostics's prepaid & other current?
Quest Diagnostics (DGX) reported prepaid & other current of $319M in Q2 2026.
How has Quest Diagnostics's prepaid & other current changed year-over-year?
Quest Diagnostics's prepaid & other current increased by 16.8% year-over-year, from $273M to $319M.
What is the long-term trend for Quest Diagnostics's prepaid & other current?
Over 5 years (2020 to 2025), Quest Diagnostics's prepaid & other current has grown at a 18.1% compound annual growth rate (CAGR), from $157M to $361M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Quest Diagnostics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude